Back

Invasive assessment of coronary microvascular dysfunction and its association with clinical outcomes in patients with acute coronary syndrome: a meta-analysis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: MINOCA and microcirculation dysfunction Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Athanasios Sakalidis

251 Air Force General Hospital, Athens (Greece)

7 More presentations in this session

Presentation thumbnail
Association between peripheral microangiopathy and coronary microvascular dysfunction in patients with ischemia and non-obstructive coronary arteries
Doctor A. Sakalidis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Long-term mortality in patients with myocardial infarction with non-obstructive coronary arteries: cardiac magnetic resonance imaging results in comparison to population-based controls
Doctor G. Gunners (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Sex differences in protocolized diagnostics for myocardial infarction with non-obstructive coronary arteries (MINOCA)
Mr B. Yosofi (Nijmegen, NL)
Abstract Slides Video
Presentation thumbnail
Incidence, trends, characteristics, and outcomes in myocardial infarction with nonobstructive coronary artery disease (MINOCA) in Manitoba
Doctor M. Zawadka (Winnipeg, CA)
Abstract Slides Video
Presentation thumbnail
Primary versus secondary type of Takotsubo syndrome
Doctor K. Bartoskova (Prague, CZ)
Abstract Slides Video

Access the full session

Session thumbnail
MINOCA and microcirculation dysfunction

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Prognostic significance of the invasive assessment of coronary microvascular dysfunction: a systematic review and meta-analysis
thumbnail
Congress Session
Fine-tuning prognostication after acute coronary syndromes
thumbnail
Congress Session
Long-term outcomes and innovations in revascularisation strategies

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources